Boston Scientific CorporationBSXNYSE
Loading
Revenue Growth AcceleratingAccelerating
Percentile Rank56
3Y CAGR+24.3%
5Y CAGR+18.8%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
+24.3%/yr
vs -7.1%/yr prior
5Y CAGR
+18.8%/yr
Recent acceleration
Acceleration
+31.4pp
Accelerating
Percentile
P56
Within normal range
vs 5Y Ago
2.4x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 4.36% |
| Q3 2025 | 0.08% |
| Q2 2025 | 8.54% |
| Q1 2025 | 2.24% |
| Q4 2024 | 8.36% |
| Q3 2024 | 2.16% |
| Q2 2024 | 6.85% |
| Q1 2024 | 3.52% |
| Q4 2023 | 5.61% |
| Q3 2023 | -2.00% |
| Q2 2023 | 6.20% |
| Q1 2023 | 4.53% |
| Q4 2022 | 2.27% |
| Q3 2022 | -2.28% |
| Q2 2022 | 7.20% |
| Q1 2022 | -3.23% |
| Q4 2021 | 6.65% |
| Q3 2021 | -4.71% |
| Q2 2021 | 11.81% |
| Q1 2021 | 1.62% |
| Q4 2020 | 1.84% |
| Q3 2020 | 32.75% |
| Q2 2020 | -21.23% |
| Q1 2020 | -12.46% |
| Q4 2019 | 7.31% |
| Q3 2019 | 2.89% |
| Q2 2019 | 5.54% |
| Q1 2019 | -2.66% |
| Q4 2018 | 7.02% |
| Q3 2018 | -3.90% |
| Q2 2018 | 4.67% |
| Q1 2018 | -1.20% |
| Q4 2017 | 8.37% |
| Q3 2017 | -1.55% |
| Q2 2017 | 4.49% |
| Q1 2017 | -1.41% |
| Q4 2016 | 4.09% |
| Q3 2016 | -0.99% |
| Q2 2016 | 8.25% |
| Q1 2016 | -0.71% |